Expected earnings - Carisma Therapeutics Inc.
Source: US Earnings Reports
Carisma Therapeutics Inc. (CARM) is expected to report for Q2 2025
Carisma Therapeutics Inc.
NASDAQ: CARM
CARM Trading
-38.7% G/L:
$0.1679 Last:
10,869,262 Volume:
$0.1587 Open:
CARM Latest News
September 02, 2025 09:50:27 am
Lasers, Lungs & Leapfrogs: Innovation Sparks Market Moves as Healthcare Stocks Surge
CARM Stock Data
$1,682,172
30,135,994
N/A
19
1291811%
Biotechnology & Life Sciences
Healthcare
US
Philadelphia
